tiprankstipranks
Eastwood Bio-Medical Canada Inc (TSE:EBM)
:EBM
Canadian Market
Want to see TSE:EBM full AI Analyst Report?

Eastwood Bio-Medical Canada (EBM) Price & Analysis

5 Followers

EBM Stock Chart & Stats

C$0.80
>-C$0.01(-1.00%)
At close: 4:00 PM EST
C$0.80
>-C$0.01(-1.00%)

Bulls Say, Bears Say

Bulls Say
High Gross MarginA ~63% gross margin indicates durable product-level profitability and pricing power for its Eleotin supplements. High gross margins give the company room to invest in R&D, marketing, and channel expansion; if SG&A is controlled, this supports path to sustained operating improvement.
Improving Cash GenerationTransitioning to positive operating and free cash flow demonstrates improving cash conversion from sales, reducing reliance on financing. Although small relative to losses, persistent positive cash flow is a structural step toward self-funding growth and stabilizing operations over the next several months.
Research-backed, Diversified DistributionA research-driven product strategy combined with multiple distribution channels (online, retail, direct, potential licensing) supports durable market access and premium positioning. This business model reduces channel concentration risk and enables scalable expansion into new geographies and partnerships.
Bears Say
Persistent Heavy LossesSustained deep losses indicate the company has not converted healthy gross margins into operating profit. Continued negative margins erode reserves, limit reinvestment in growth, and increase reliance on external capital, posing a durable headwind to improving financial resilience.
Negative Shareholders' EquityNegative equity is a structural solvency concern that restricts financial flexibility. It can deter lenders and partners, complicate fundraising, and constrain strategic options like acquisitions or large marketing investments, making balance-sheet repair a multimonth priority.
Declining TTM RevenueAn 8% TTM revenue decline undermines scalability given fixed manufacturing and R&D costs. Falling top-line undermines the ability to leverage gross margins into operating profits, makes recent cash flow gains fragile, and raises execution risk for restoring sustainable growth.

EBM FAQ

What was Eastwood Bio-Medical Canada Inc’s price range in the past 12 months?
Eastwood Bio-Medical Canada Inc lowest stock price was C$0.29 and its highest was C$1.10 in the past 12 months.
    What is Eastwood Bio-Medical Canada Inc’s market cap?
    Eastwood Bio-Medical Canada Inc’s market cap is C$65.44M.
      When is Eastwood Bio-Medical Canada Inc’s upcoming earnings report date?
      Eastwood Bio-Medical Canada Inc’s upcoming earnings report date is Jun 25, 2026 which is in 11 days.
        How were Eastwood Bio-Medical Canada Inc’s earnings last quarter?
        Currently, no data Available
        Is Eastwood Bio-Medical Canada Inc overvalued?
        According to Wall Street analysts Eastwood Bio-Medical Canada Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Eastwood Bio-Medical Canada Inc pay dividends?
          Eastwood Bio-Medical Canada Inc does not currently pay dividends.
          What is Eastwood Bio-Medical Canada Inc’s EPS estimate?
          Eastwood Bio-Medical Canada Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Eastwood Bio-Medical Canada Inc have?
          Eastwood Bio-Medical Canada Inc has 68,885,970 shares outstanding.
            What happened to Eastwood Bio-Medical Canada Inc’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Eastwood Bio-Medical Canada Inc?
            Currently, no hedge funds are holding shares in TSE:EBM
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Eastwood Bio-Medical Canada Inc

              Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is a company focused on the worldwide marketing and distribution of natural health products. Operating under the Eleotin brand, their offerings are available across Canada, the United States, and Asian regions. The firm's core mission is to deliver natural remedies for prevalent metabolic disorders, including issues with blood glucose regulation, hypertension, and obesity. Their extensive portfolio of licensed Eleotin products addresses diverse health requirements. For individuals experiencing spleen deficiency, appetite loss, or fatigue, Eleotin A 700 provides support. Eleotin AL88 serves as a laxative, while Eleotin Cal20 aids in the maintenance of healthy bones and teeth. Eleotin V3D is formulated for the development and upkeep of strong bones, teeth, and overall well-being. To support cardiovascular health, they offer Eleotin G2000. Eleotin H55 is designed to act as a sedative and alleviate tension, and Eleotin Zn330 is vital for tissue formation and metabolic processes. Furthermore, their product line includes Eleotin Bentley, which promotes balanced glucose levels, and Eleotin LBM, intended for hypertension relief.

              Eastwood Bio-Medical Canada (EBM) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Arch Biopartners
              Diagnos
              Willow Biosciences Inc
              ZYUS Life Sciences
              Sona Nanotech Inc

              Options Prices

              Currently, No data available
              ---
              Popular Stocks